Polymorphism of the tumour necrosis factor-α gene at position -308 and renal manifestation of primary Sjögren's syndrome [3]

Rheumatology

Volumn 43, Issue 1, 2004, Pages 106-107

  Pertovaara, Marja ^a   Hulkkonen, J ^b   Antonen, J ^a,b   Holopainen, P ^c   Laippala, P ^a,d   Pasternack, A ^b   Hurme, M ^a,b  

^a Tampere University Hospital   (Hungary)

^b UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^c Finnish Red Cross   (Finland)

^d UNIVERSITY OF TAMPERE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM CHLORIDE; CYTOKINE; DNA; HLA DR ANTIGEN; HLA DR3 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALLELE; CLINICAL FEATURE; CONTROLLED STUDY; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INFORMED CONSENT; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY TUBULE ACIDOSIS; LETTER; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PATIENT SELECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SJOEGREN SYNDROME; URINARY EXCRETION;

AGED; FEMALE; GENE FREQUENCY; HUMANS; KIDNEY; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SJOGREN'S SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0345832236     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg446     Document Type: Letter

References (10)

1. Fox RI, Kang HI, Ando D et al. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J Immunol 1994; 152:5532-9.
2. Brennan FM, Feldmann M. Cytokines in autoimmunity. Curr Opin Immunol 1996;8:872-7.
3. Baud L, Ardaillou R. Tumor necrosis factor in renal injury. Miner Electrolyte Metab 1995;21:336-41.
4. Wilson AG, Symons JA, McDowell TL et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94: 3195-9.
5. Hulkkonen J, Pertovaara M, Antonen J, Pasternack A, Hurme M. Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of IL-6 gene in primary Sjögren's syndrome (pSS) and correlate with clinical manifestations of the disease. Rheumatology 2001;40:656-61.
6. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 2002;61:554-9.
7. Pertovaara M, Korpela M, Kouri T, Pasternack A. The occurrence of renal involvement in primary Sjögren's syndrome: a study of 78 patients. Rheumatology 1999;38:1113-20.
8. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
9. Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992;1:353.
10. Westman P, Kuismin T, Partanen J, Koskimies S. An HLA-DR typing protocol using group-specific PCR-amplification followed by restriction enzyme digests. Eur J Immunogenet 1993;20:103-9.